KalVista Pharmaceuticals (KALV) Short term Debt (2014 - 2016)

KalVista Pharmaceuticals (KALV) has 3 years of Short term Debt data on file, last reported at $2.0 million in Q1 2016.

• For the quarter ending Q1 2016, Short term Debt rose 81.4% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2016 stood at $2.0 million (up 81.4% YoY), and the FY2016 full-year result was $127000.0, changed N/A from the prior year.
• Short term Debt advanced to $2.0 million in Q1 2016, from $1.5 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $4.4 million in Q4 2014 to a low of $480000.0 in Q2 2015.
• A 3-year average of $1.7 million and a median of $1.3 million in 2015 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt plunged 67.19% in 2015 and soared 81.4% in 2016, its largest moves.
• Tracing KALV's Short term Debt over 3 years: stood at $4.4 million in 2014, then sank by 67.19% to $1.5 million in 2015, then jumped by 34.02% to $2.0 million in 2016.
• Business Quant data shows KALV's Short term Debt at $2.0 million in Q1 2016, $1.5 million in Q4 2015, and $965000.0 in Q3 2015.